ArticleFrontiers in endocrinology2026
Modulation of chemokine secretion and oxidative stress
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Perchlorate, nitrate, and thiocyanate are thyroid disruptors. Emerging evidence suggests they may exert further effects independent of iodide uptake inhibition, influencing oxidative stress and thyroid tumour development. This study aimed to assess their effects on cell viability, proliferation, reactive oxygen species (ROS) production, and chemokine expression in normal human thyroid cells and thyroid cancer cell lines. Methods: Thyroid cells, both normal (NHT, in primary cultures) and cancer (TPC-1 and 8505C), were exposed to increasing concentrations of perchlorate, nitrate, or thiocyanate for 24 hours. Cell viability and proliferation were assessed in each cell type. Intracellular ROS production was measured using H Results: None of the three anions significantly affected viability in NHT or 8505C cells, whereas high-dose thiocyanate reduced viability in TPC-1 cells. Proliferative responses were modest and cell-type specific, occurring mainly at the highest concentrations tested. Perchlorate induced a biphasic increase in ROS production in NHT, while thiocyanate slightly reduced ROS levels in TPC-1 cells; no consistent effects were observed in 8505C cells. Thiocyanate consistently increased CXCL8 secretion in NHT and TPC-1 cells, with a concentration-dependent but non-monotonic pattern, whereas nitrate and perchlorate had minimal effects. CXCL10 protein was undetectable in all conditions, despite significant and cell-specific modulation of CXCL10 mRNA expression. Conclusions: Beyond their role as NIS inhibitors, perchlorate, nitrate and thiocyanate modulate oxidative stress and chemokine secretion in human thyroid cells. Thiocyanate promotes a pro-inflammatory phenotype, potentially favouring a tumour-promoting thyroid microenvironment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.